Kovesdy CP. Epidemiology of chronic kidney disease: An update 2022. Kidney Int Suppl 12: 7–11, 2022
Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, et al: Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol 13: 90–103, 2017 PubMed
KDOQI; National Kidney Foundation: KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47[Suppl 3]: S11–S145, 2006 PubMed
Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, et al; CKD Prognosis Consortium: Relationship of estimated GFR and albuminuria to concurrent laboratory abnormalities: An individual participant data meta-analysis in a global consortium. Am J Kidney Dis 73: 206–217, 2019 PubMed
Stauffer ME, Fan T: Prevalence of anemia in chronic kidney disease in the United States. PLoS One 9: e84943, 2014 PubMed
Portolés J, Martín L, Broseta JJ, Cases A: Anemia in chronic kidney disease: From pathophysiology and current treatments, to future agents. Front Med (Lausanne) 8: 642296, 2021 PubMed
Drüeke TB, Parfrey PS: Summary of the KDIGO guideline on anemia and comment: Reading between the (guide)line(s). Kidney Int 82: 952–960, 2012 PubMed
Ma J, Dou Y, Zhang H, Thijssen S, Williams S, Kuntsevich V, et al: Correlation between inflammatory biomarkers and red blood cell life span in chronic hemodialysis patients. Blood Purif 43: 200–205, 2017 PubMed
Fishbane S, Spinowitz B: Update on anemia in ESRD and earlier stages of CKD: Core curriculum 2018. Am J Kidney Dis 71: 423–435, 2018 PubMed
Zeidan A, Bhandari S: Anemia in peritoneal dialysis patients: Iron repletion, current and future therapies. Perit Dial Int 37: 6–13, 2017 PubMed
Shepshelovich D, Rozen-Zvi B, Avni T, Gafter U, Gafter-Gvili A: Intravenous versus oral iron supplementation for the treatment of anemia in CKD: An updated systematic review and meta-analysis. Am J Kidney Dis 68: 677–690, 2016 PubMed
Li H, Wang SX: Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. Perit Dial Int 28: 149–154, 2008 PubMed
Wong MMY, Tu C, Li Y, Perlman RL, Pecoits-Filho R, Lopes AA, et al; CKDopps Investigators: Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: Often unmeasured, variably treated. Clin Kidney J 13: 613–624, 2019 PubMed
Lopes MB, Tu C, Zee J, Guedes M, Pisoni RL, Robinson BM, et al: A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: A multinational analysis of CKDopps. Sci Rep 11: 1784, 2021 PubMed
Locatelli F, Covic A, Eckardt KU, Wiecek A, Vanholder R; ERA-EDTA ERBP Advisory Board: Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 24: 348–354, 2009 PubMed
National Institute for Health and Care Excellence: Chronic Kidney Disease: Managing Anaemia. NICE Guidelines (NG203), 2021. Available at: https://www.nice.org.uk/guidance/ng203. Accessed September 2022.
Erslev A: Erythropoietin coming of age. N Engl J Med 316: 101–103, 1987 PubMed
Locatelli F, Hannedouche T, Fishbane S, Morgan Z, Oguey D, White WB: Cardiovascular safety and all-cause mortality of methoxy polyethylene glycol-epoetin beta and other erythropoiesis-stimulating agents in anemia of CKD: A randomized noninferiority trial. Clin J Am Soc Nephrol 14: 1701–1710, 2019 PubMed
Virani SA, Khosla A, Levin A. Chronic kidney disease, heart failure and anemia. Can J Cardiol 24 (Suppl B): 22B–24B, 2008.
Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, Bradbury BD, et al: Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: A retrospective cohort analysis. Am J Nephrol 41: 354–361, 2015 PubMed
Li PKT, Choy ASM, Bavanandan S, Chen W, Foo M, Kanjanabuch T, et al: Anemia management in peritoneal dialysis: Perspectives from the Asia Pacific region. Kidney Med 3: 405–411, 2021 PubMed
Akizawa T, Otsuka T, Reusch M, Ueno M: Intermittent oral dosing of roxadustat in peritoneal dialysis chronic kidney disease patients with anemia: A randomized, phase 3, multicenter, open-label study. Ther Apher Dial 24: 115–125, 2020 PubMed
Manns BJ, White CT, Madore F, Moist LM, Klarenbach SW, Barrett BJ, et al: Introduction to the Canadian Society of Nephrology clinical practice guidelines for the management of anemia associated with chronic kidney disease. Kidney Int Suppl 74: S1–S3, 2008 PubMed
Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, et al; ERA-EDTA ERBP Advisory Board: Kidney disease: Improving global outcomes guidelines on anaemia management in chronic kidney disease: A European renal best practice position statement. Nephrol Dial Transplant 28: 1346–1359, 2013 PubMed
Liu L, Zhang L, Liu GJ, Fu P: Peritoneal dialysis for acute kidney injury. Cochrane Database Syst Rev 12: CD011457, 2017 PubMed
Gabriel DP, Caramori JT, Martim LC, Barretti P, Balbi AL: High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl 73: S87–S93, 2008 PubMed
Ponce D, Berbel MN, Abrão JM, Goes CR, Balbi AL: A randomized clinical trial of high volume peritoneal dialysis versus extended daily hemodialysis for acute kidney injury patients. Int Urol Nephrol 45: 869–878, 2013 PubMed
Al-Hwiesh A, Abdul-Rahman I, Finkelstein F, Divino-Filho J, Qutub H, Al-Audah N, et al: Acute kidney injury in critically ill patients: A prospective randomized study of tidal peritoneal dialysis versus continuous renal replacement therapy. Ther Apher Dial 22: 371–379, 2018 PubMed
Ye Z, Wang Y, Ge L, Guyatt GH, Collister D, Alhazzani W, et al: Comparing renal replacement therapy modalities in critically ill patients with acute kidney injury: A systematic review and network meta-analysis. Crit Care Explor 3: e0399, 2021 PubMed
Shanmugalingam R, Makris A, Hassan HC, Li Y, DeGuzman I, Nandakoban H, et al: The utility of sonographic assessment in selecting patients for percutaneous insertion of peritoneal dialysis catheter. Perit Dial Int 37: 434–442, 2017 PubMed
Cullis B, Al-Hwiesh A, Kilonzo K, McCulloch M, Niang A, Nourse P, et al: ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 update (adults). Perit Dial Int 41: 15–31, 2021 PubMed
Ponce D, Berbel MN, Regina de Goes C, Almeida CT, Balbi AL: High-volume peritoneal dialysis in acute kidney injury: Indications and limitations. Clin J Am Soc Nephrol 7: 887–894, 2012 PubMed
Ponce D, Brito GA, Abrão JG, Balb AL: Different prescribed doses of high-volume peritoneal dialysis and outcome of patients with acute kidney injury. Adv Perit Dial 27: 118–124, 2011 PubMed
Parapiboon W, Jamratpan T: Intensive versus minimal standard dosage for peritoneal dialysis in acute kidney injury: A randomized pilot study. Perit Dial Int 37: 523–528, 2017 PubMed
Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, et al: ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int 42: 110–153, 2022 PubMed
Chen W, Caplin N, El Shamy O, Sharma S, Sourial MY, Ross MJ, et al; NYC-PD Consortium: Use of peritoneal dialysis for acute kidney injury during the COVID-19 pandemic in New York City: A multicenter observational study. Kidney Int 100: 2–5, 2021 PubMed
El Shamy O, Patel N, Abdelbaset MH, Chenet L, Tokita J, Lookstein R, et al: Acute start peritoneal dialysis during the COVID-19 pandemic: Outcomes and experiences. J Am Soc Nephrol 31: 1680–1682, 2020 PubMed
Parapiboon W, Ponce D, Cullis B: Acute peritoneal dialysis in COVID-19. Perit Dial Int 40: 359–362, 2020 PubMed
Ponce D, Balbi AL, Durand JB, Moretta G, Divino-Filho JC: Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury. Clin Kidney J 13: 269–273, 2020 PubMed
Candellier A, Goffin E: Can SARS-CoV-2 be found in the effluent from peritoneal dialysis patients? Clin Kidney J 14: 2124–2126, 2021 PubMed
Sourial MY, Gone A, Uribarri J, Srivatana V, Sharma S, Shimonov D, et al; New York City Peritoneal Dialysis Consortium: Outcomes of PD for AKI treatment during COVID-19 in New York City: A multicenter study. Perit Dial Int 43: 13–22, 2023 PubMed
Bowes E, Joslin J, Braide-Azikiwe DCB, Tulley C, Bramham K, Saha S, et al: Acute peritoneal dialysis with percutaneous catheter insertion for COVID-19-associated acute kidney injury in intensive care: Experience from a UK tertiary center. Kidney Int Rep 6: 265–271, 2021 PubMed
Caplin NJ, Zhdanova O, Tandon M, Thompson N, Patel D, Soomro Q, et al: Acute peritoneal dialysis during the COVID-19 pandemic at Bellevue Hospital in New York City. Kidney360 1: 1345–1352, 2020 PubMed
Soomro QH, Mukherjee V, Amerling R, Caplin N: Case series of acute peritoneal dialysis in the prone position for acute kidney injury during the Covid-19 pandemic: Prone to complications? Perit Dial Int 41: 328–332, 2021 PubMed
Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73: 391–398, 2008 PubMed
Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, et al: Global prevalence of protein-energy wasting in kidney disease: A meta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr 28: 380–392, 2018 PubMed
Ren M, Sheng Q, Xie X, Zhang X, Han F, Chen J: Geriatric nutritional risk index is associated with mortality in peritoneal dialysis patients. Intern Med J 50: 470–476, 2020 PubMed
Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, et al: Etiology of the protein-energy wasting syndrome in chronic kidney disease: A consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr 23: 77–90, 2013 PubMed
Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, et al: KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 update. Am J Kidney Dis 76[Suppl 1]: S1–S107, 2020 PubMed
Wang AY, Brimble KS, Brunier G, Holt SG, Jha V, Johnson DW, et al: ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I—Assessment and management of various cardiovascular risk factors. Perit Dial Int 35: 379–387, 2015 PubMed
Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ: Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 64: 1838–1844, 2003 PubMed
Stack AG, Murthy BV, Molony DA: Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States. Kidney Int 65: 2398–2408, 2004 PubMed
Obi Y, Streja E, Mehrotra R, Rivara MB, Rhee CM, Soohoo M, et al: Impact of obesity on modality longevity, residual kidney function, peritonitis, and survival among incident peritoneal dialysis patients. Am J Kidney Dis 71: 802–813, 2018 PubMed
Verger C, Ronco C, Van Biesen W, Heaf J, Vrtovsnik F, Vera Rivera M, et al: Association of prescription with body composition and patient outcomes in incident peritoneal dialysis patients. Front Med (Lausanne) 8: 737165, 2021 PubMed
Choy AS-M, Chow K-M, Kwan BC-H, Cheng PM-S, Kwong VW-K, Pang W-F, et al: Weight change during the first year of peritoneal dialysis: Risk factors and prognostic implications. Hong Kong J Nephrol 17: 28–35, 2015
Than WH, Ng JKC, Chan GCK, Fung W, Szeto CC: The prognostic impact of weight gain after peritoneal dialysis. Nephrol Dial Transplant ;36[Suppl 1],gfab101.0026, 2021
Parthasarathy R, Oei E, Fan SL: Clinical value of body composition monitor to evaluate lean and fat tissue mass in peritoneal dialysis. Eur J Clin Nutr 73: 1520–1528, 2019 PubMed
Ng JK, Chan GC, Kam KK, Tian N, Than WH, Cheng PM, et al: The impact of volume overload on the longitudinal change of adipose and lean tissue mass in incident chinese peritoneal dialysis patients. Nutrients 14: 4076, 2022 PubMed
Kim C, Kim JK, Lee HS, Kim SG, Song YR: Longitudinal changes in body composition are associated with all-cause mortality in patients on peritoneal dialysis. Clin Nutr 40: 120–126, 2021 PubMed
Popovic V, Zerahn B, Heaf JG: Comparison of dual energy x-ray absorptiometry and bioimpedance in assessing body composition and nutrition in peritoneal dialysis patients. J Ren Nutr 27: 355–363, 2017 PubMed
Chamney PW, Wabel P, Moissl UM, Müller MJ, Bosy-Westphal A, Korth O, et al: A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 85: 80–89, 2007 PubMed
Chan GC, Than WH, Kwan BC, Lai KB, Chan RC, Teoh JY, et al: Adipose and serum zinc alpha-2-glycoprotein (ZAG) expressions predict longitudinal change of adiposity, wasting and predict survival in dialysis patients. Sci Rep 12: 9087, 2022 PubMed
Yoowannakul S, Tangvoraphonkchai K, Davenport A: The prevalence of muscle wasting (sarcopenia) in peritoneal dialysis patients varies with ethnicity due to differences in muscle mass measured by bioimpedance. Eur J Clin Nutr 72: 381–387, 2018 PubMed
Szeto CC, Kong J, Wu AK, Wong TY, Wang AY, Li PK: The role of lean body mass as a nutritional index in Chinese peritoneal dialysis patients--comparison of creatinine kinetics method and anthropometric method. Perit Dial Int 20: 708–714, 2000 PubMed
Hiruy AF, Opoku S, Xiong Q, Jin Q, Zhao J, Lin X, et al: Nutritional predictors associated with malnutrition in continuous ambulatory peritoneal dialysis patients. Clin Nutr ESPEN 45: 454–461, 2021 PubMed
Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13: 1307–1320, 2002 PubMed
Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7: 198–207, 1996 PubMed
Chan GC, Ng JK, Chow KM, Kwong VW, Pang WF, Cheng PM, et al: Impact of frailty and its inter-relationship with lean tissue wasting and malnutrition on kidney transplant waitlist candidacy and delisting. Clin Nutr 40: 5620–5629, 2021 PubMed
Chan GC, Ng JK, Chow KM, Kwan BC, Kwong VW, Pang WF, et al: Depression does not predict clinical outcome of Chinese peritoneal Dialysis patients after adjusting for the degree of frailty. BMC Nephrol 21: 329, 2020 PubMed
Chan GC, N G JK, Chow KM, Kwong VW, Pang WF, Cheng PM, et al: Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients. PLoS One 15: e0241242, 2020 PubMed
Steiber AL, Kalantar-Zadeh K, Secker D, McCarthy M, Sehgal A, McCann L: Subjective Global Assessment in chronic kidney disease: A review. J Ren Nutr 14: 191–200, 2004 PubMed
Chan GC, Ng JK, Chow KM, Kwong VW, Pang WF, Cheng PM, et al: Progression in Physical Frailty in Peritoneal Dialysis Patients. Kidney Blood Press Res 46: 342–351, 2021 PubMed
Chan GC, Ng JK, Chow KM, Cheng PM, Law MC, Leung CB, et al: Polypharmacy predicts onset and transition of frailty, malnutrition, and adverse outcomes in peritoneal dialysis patient. J Nutr Health Aging 26: 1054–1060, 2022 PubMed
Paudel K, Visser A, Burke S, Samad N, Fan SL: Can bioimpedance measurements of lean and fat tissue mass replace subjective global assessments in peritoneal dialysis patients? J Ren Nutr 25: 480–487, 2015 PubMed
Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38: 1251–1263, 2001 PubMed
Chan JY, Che KI, Lam KM, Chow KM, Chung KY, Li PK, et al: Comprehensive malnutrition inflammation score as a marker of nutritional status in Chinese peritoneal dialysis patients. Nephrology (Carlton) 12: 130–134, 2007 PubMed
Kittiskulnam P, Chuengsaman P, Kanjanabuch T, Katesomboon S, Tungsanga S, Tiskajornsiri K, et al: Protein-energy wasting and mortality risk prediction among peritoneal dialysis patients. J Ren Nutr 31: 679–686, 2021 PubMed
Cueto-Manzano AM, Romero-García ARJ, Cortés-Sanabria L, Márquez-Herrera RM, Martin-Del-Campo F, Jacobo-Arias F, et al: Systemic inflammation may limit the effect of protein supplement on nutritional status in peritoneal dialysis. Clin Nutr ESPEN 49: 307–313, 2022 PubMed
Chung SH, Heimbürger O, Stenvinkel P, Bergström J, Lindholm B: Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 16: 2240–2245, 2001 PubMed
Szeto CC, Kwan BC, Chow KM, Chung S, Yu V, Cheng PM, et al: Predictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 35: 180–188, 2015 PubMed
Procaccini C, Jirillo E, Matarese G: Leptin as an immunomodulator. Mol Aspects Med 33: 35–45, 2012 PubMed
Than WH, Chan GC-K, Ng JK-C, Szeto C-C: The role of obesity on chronic kidney disease development, progression, and cardiovascular complications. Adv Biomarker Sci Technol. 2: 24–34, 2020
Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD: Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 42: 864–881, 2003 PubMed
Szeto CC, Kwan BC, Chow KM, Leung CB, Law MC, Li PK: Prognostic value of arterial pulse wave velocity in peritoneal dialysis patients. Am J Nephrol 35: 127–133, 2012 PubMed
Chow KM, Szeto CC, Leung CB, Kwan BC, Law MC, Li PK: A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int 25: 374–379, 2005 PubMed
Grant CJ, Harrison LE, Hoad CL, Marciani L, Gowland PA, McIntyre CW: Patients with chronic kidney disease have abnormal upper gastro-intestinal tract digestive function: A study of uremic enteropathy. J Gastroenterol Hepatol 32: 372–377, 2017 PubMed
Szeto CC, Kwan BC, Chow KM, Lai KB, Chung KY, Leung CB, et al: Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 3: 431–436, 2008 PubMed
McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, et al: Circulating endotoxemia: A novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 6: 133–141, 2011 PubMed
Szeto CC, Kwan BC, Chow KM, Kwok JS, Lai KB, Cheng PM, et al: Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients. PLoS One 10: e0125162, 2015 PubMed
Poon PY, Ng JK, Fung WW, Chow KM, Kwan BC, Li PK, et al: Relationship between plasma endocan level and clinical outcome of chinese peritoneal dialysis patients. Kidney Blood Press Res 44: 1259–1270, 2019 PubMed
Kwan BC, Chow KM, Leung CB, Law MC, Cheng PM, Yu V, et al: Circulating bacterial-derived DNA fragments as a marker of systemic inflammation in peritoneal dialysis. Nephrol Dial Transplant 28: 2139–2145, 2013 PubMed
Szeto CC, Johnson DW: Low GDP solution and glucose-sparing strategies for peritoneal dialysis. Semin Nephrol 37: 30–42, 2017 PubMed
Szeto CC, McIntyre CW, Li PK: Circulating bacterial fragments as cardiovascular risk factors in CKD. J Am Soc Nephrol 29: 1601–1608, 2018 PubMed
Tian N, Li L, Ng JK, Li PK: The potential benefits and controversies of probiotics use in patients at different stages of chronic kidney disease. Nutrients 14: 4044, 2022 PubMed
Szeto CC, Wong TY, Leung CB, Wang AY, Law MC, Lui SF, et al: Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 58: 400–407, 2000 PubMed
Szeto CC, Wong TY, Chow KM, Leung CB, Wang AY, Lui SF, et al: The impact of increasing the daytime dialysis exchange frequency on peritoneal dialysis adequacy and nutritional status of Chinese anuric patients. Perit Dial Int 22: 197–203, 2002 PubMed
Szeto CC, Chow KM: Metabolic acidosis and malnutrition in dialysis patients. Semin Dial 17: 371–375, 2004 PubMed
Stein A, Moorhouse J, Iles-Smith H, Baker F, Johnstone J, James G, et al: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52: 1089–1095, 1997 PubMed
Szeto CC, Wong TY, Chow KM, Leung CB, Li PK: Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: A randomized placebo-control trial. J Am Soc Nephrol 14: 2119–2126, 2003 PubMed
Szeto CC, Chan GC, Ng JK, Chow KM, Kwan BC, Cheng PM, et al: Depression and physical frailty have additive effect on the nutritional status and clinical outcome of chinese peritoneal dialysis. Kidney Blood Press Res 43: 914–923, 2018 PubMed
Gokal R, Moberly J, Lindholm B, Mujais S: Metabolic and laboratory effects of icodextrin. Kidney Int Suppl 62: S62–S71, 2002 PubMed
Sahathevan S, Se CH, Ng S, Khor BH, Chinna K, Goh BL, et al: Clinical efficacy and feasibility of whey protein isolates supplementation in malnourished peritoneal dialysis patients: A multicenter, parallel, open-label randomized controlled trial. Clin Nutr ESPEN 25: 68–77, 2018 PubMed
Mah JY, Choy SW, Roberts MA, Desai AM, Corken M, Gwini SM, et al: Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev 5: CD012616, 2020 PubMed
Teixidó-Planas J, Ortiz A, Coronel F, Montenegro J, López-Menchero R, Ortíz R, et al: Oral protein-energy supplements in peritoneal dialysis: A multicenter study. Perit Dial Int 25: 163–172, 2005 PubMed
Tjiong HL, van den Berg JW, Wattimena JL, Rietveld T, van Dijk LJ, van der Wiel AM, et al: Dialysate as food: Combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol 16: 1486–1493, 2005 PubMed
Li FK, Chan LY, Woo JC, Ho SK, Lo WK, Lai KN, et al: A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis 42: 173–183, 2003 PubMed
Li PK, Chan GC, Chen J, Chen HC, Cheng YL, Fan SL, et al: Tackling dialysis burden around the world: A global challenge. Kidney Dis 7: 167–175, 2021 PubMed
Li PK, Lu W, Mak SK, Boudville N, Yu X, Wu MJ, et al: Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact. Nephrology (Carlton) 27: 787–794, 2022 PubMed
Xu Y, Zhang Y, Yang B, Luo S, Yang Z, Johnson DW, et al: Prevention of peritoneal dialysis-related peritonitis by regular patient retraining via technique inspection or oral education: A randomized controlled trial. Nephrol Dial Transplant 35: 676–686, 2020 PubMed
Szeto CC, Lo WK, Li PK: Clinical practice guidelines for the provision of renal service in Hong Kong: Peritoneal dialysis. Nephrology (Carlton) 24[Suppl 1]: 27–40, 2019 PubMed
Leung WY, Ng MSN, Hau AKC, So WKW: Retraining programme for older patients undergoing peritoneal dialysis: A randomised controlled trial. J Ren Care 2022 Dec 4. doi: 10.1111/jorc.12450. Epub ahead of print. PMID: 36463502. PubMed
Szeto CC, Li PK: Peritoneal dialysis-associated peritonitis. Clin J Am Soc Nephrol 14: 1100–1105, 2019 PubMed
Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley C, et al: Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis. Clin J Am Soc Nephrol 12: 1090–1099, 2017 PubMed
Manera KE, Johnson DW, Craig JC, Shen JI, Gutman T, Cho Y, et al; SONG-PD Workshop Investigators: Establishing a core outcome set for peritoneal dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology-Peritoneal Dialysis) consensus workshop. Am J Kidney Dis 75: 404–412, 2020 PubMed
Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al: ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int 36: 481–508, 2016 PubMed
Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, et al: Peritoneal dialysis-related infection rates and outcomes: Results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis 76: 42–53, 2020 PubMed
Marshall MR: A systematic review of peritoneal dialysis-related peritonitis rates over time from national or regional population-based registries and databases. Perit Dial Int 42: 39–47, 2022 PubMed
Gweon TG, Jung SH, Kim SW, Lee KM, Cheung DY, Lee BI, et al: Risk factors for peritonitis in patients on continuous ambulatory peritoneal dialysis who undergo colonoscopy: A retrospective multicentre study. BMC Gastroenterol 19: 175, 2019 PubMed
Suzuki Y, Mizuno M, Kojima H, Sato Y, Kim H, Kinashi H, et al: Oral antibiotics are effective for preventing colonoscopy-associated peritonitis as a preemptive therapy in patients on peritoneal dialysis. Intern Med 60: 353–356, 2021 PubMed
Wu HH, Li IJ, Weng CH, Lee CC, Chen YC, Chang MY, et al: Prophylactic antibiotics for endoscopy-associated peritonitis in peritoneal dialysis patients. PLoS One 8: e71532, 2013 PubMed
Fan PY, Chan MJ, Lin SH, Wu HH, Chang MY, Tian YC, et al: Prophylactic antibiotic reduces the risk of peritonitis after invasive gynecologic procedures. Perit Dial Int 39: 356–361, 2019 PubMed
Takkavatakarn K, Aniwan S, Kamjohnjiraphunt N, Towannang P, Maeboonruen N, Saejew T, et al: Whether antibiotic prophylaxis is necessary in peritoneal dialysis patients undergoing elective colonoscopy with postprocedural peritoneal lavage. Kidney Int Rep 5: 1783–1787, 2020 PubMed
Chan GC, Wong SH, Ng JK, Li PK, Szeto CC, Chow KM: Risk of peritonitis after gastroscopy in peritoneal dialysis patients. Perit Dial Int 42: 162–170, 2022 PubMed
Szeto CC, Chow KM, Kwan BC, Leung CB, Chung KY, Law MC, et al: Hypokalemia in Chinese peritoneal dialysis patients: Prevalence and prognostic implication. Am J Kidney Dis 46: 128–135, 2005 PubMed
Davies SJ, Zhao J, Morgenstern H, Zee J, Bieber B, Fuller DS, et al; PDOPPS Dialysis Prescription and Fluid Management Working Group: Low serum potassium levels and clinical outcomes in peritoneal dialysis-international results from PDOPPS. Kidney Int Rep 6: 313–324, 2020 PubMed
Pichitporn W, Kanjanabuch T, Phannajit J, Puapatanakul P, Chuengsaman P, Parapiboon W, et al: Efficacy of potassium supplementation in hypokalemic patients receiving peritoneal dialysis: A randomized controlled trial. Am J Kidney Dis 80: 580–588.e1, 2022 PubMed
Piraino BM: Correction of hypokalemia in peritoneal dialysis patients may decrease peritonitis risk. Am J Kidney Dis 80: 564–565, 2022 PubMed
Mu H, Yang M, Zhang Y, Zhang Y, Wang J, Yuan W, et al: Pet-related Pasteurella multocida induced peritonitis in peritoneal dialysis: A case report and review of the literatures. BMC Nephrol 21: 102, 2020 PubMed
Boudville N, McCullough K, Bieber B, Pisoni R, Kanjanabuch T, Kawanishi H, et al: A different PET test: The relationship between pet ownership and peritonitis risk in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Perit Dial Int 43: 263–267, 2023 PubMed
Muthucumarana K, Howson P, Crawford D, Burrows S, Swaminathan R, Irish A: The relationship between presentation and the time of initial administration of antibiotics with outcomes of peritonitis in peritoneal dialysis Patients: The PROMPT study. Kidney Int Rep 1: 65–72, 2016 PubMed
Oki R, Tsuji S, Hamasaki Y, Komaru Y, Miyamoto Y, Matsuura R, et al: Time until treatment initiation is associated with catheter survival in peritoneal dialysis-related peritonitis. Sci Rep 11: 6547, 2021 PubMed
So SWY, Chen L, Woo AYH, Ng DMH, Wong JKW, Chow KM, et al: Stability and compatibility of antibiotics in peritoneal dialysis solutions. Clin Kidney J 15: 1071–1078, 2022 PubMed
Li PK, Ip M, Law MC, Szeto CC, Leung CB, Wong TY, et al: Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis. Perit Dial Int 20: 232–234, 2000 PubMed
Wong KM, Chan YH, Cheung CY, Chak WL, Choi KS, Leung SH, et al: Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis. Am J Kidney Dis 38: 127–131, 2001 PubMed
Kitrungphaiboon T, Puapatanakul P, Chuengsaman P, Tiskajornsiri K, Halue G, Siribamrungwong M, et al: Intraperitoneal cefepime monotherapy versus combination therapy of cefazolin plus ceftazidime for empirical treatment of CAPD-associated peritonitis: A multicenter, open-label, noninferiority, randomized, controlled trial. Am J Kidney Dis 74: 601–609, 2019 PubMed
van der Hulst RJ, Boeschoten EW, Nielsen FW, Struijk DG, Dreschler WD, Tange RA: Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin. ORL J Otorhinolaryngol Relat Spec 53: 19–22, 1991 PubMed
Chong TK, Piraino B, Bernardini J: Vestibular toxicity due to gentamicin in peritoneal dialysis patients. Perit Dial Int 11: 152–155, 1991 PubMed
Kranzer K, Elamin WF, Cox H, Seddon JA, Ford N, Drobniewski F: A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: Implications for the treatment of multidrug-resistant TB. Thorax 70: 1070–1077, 2015 PubMed
Lam E, Ting Kayla Lien Y, Kraft WK, Stickle DF, Piraino B, Zhang J: Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis. Clin Transl Sci 15: 649–657, 2022 PubMed
Falbo Dos Reis P, Barretti P, Marinho L, Balbi AL, Awdishu L, Ponce D: Pharmacokinetics of intraperitoneal vancomycin and amikacin in automated peritoneal dialysis patients with peritonitis. Front Pharmacol 12: 658014, 2021 PubMed
Triyawatanyu P, Chariyavilaskul P, Phaisal W, Peerapornratana S, Kanjanabuch T, Praditpornsilpa K, et al: Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis. Perit Dial Int 40: 179–184, 2020 PubMed
Fung WW, Chow KM, Li PK, Szeto CC: Clinical course of peritoneal dialysis-related peritonitis due to non-tuberculosis mycobacterium: A single centre experience spanning 20 years. Perit Dial Int 42: 204–211, 2022 PubMed
Xu R, Chen Y, Luo S, Xu Y, Zheng B, Zheng Y, et al: Clinical characteristics and outcomes of peritoneal dialysis-related peritonitis with different trends of change in effluent white cell count: A longitudinal study. Perit Dial Int 33: 436–444, 2013 PubMed
Tantiyavarong P, Traitanon O, Chuengsaman P, Patumanond J, Tasanarong A: Dialysate white blood cell change after initial antibiotic treatment represented the patterns of response in peritoneal dialysis-related peritonitis. Int J Nephrol 2016: 6217135, 2016 PubMed
Szeto CC, Ng JK, Wing-Shing Fung W, Chan GC, Cheng PM, Lai KB, et al: Extended antibiotic therapy for the prevention of relapsing and recurrent peritonitis in peritoneal dialysis patients: A randomized controlled trial. Clin Kidney J 14: 991–997, 2021 PubMed
Bello AK, Okpechi IG, Osman MA, Cho Y, Cullis B, Htay H, et al: Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol 18: 779–793, 2022 PubMed
Pravoverov LV, Zheng S, Parikh R, Tan TC, Bhalla N, Reddy C, et al: Trends associated with large-scale expansion of peritoneal dialysis within an integrated care delivery model. JAMA Intern Med 179: 1537–1542, 2019 PubMed
Couchoud C, Bolignano D, Nistor I, Jager KJ, Heaf J, Heimburger O, et al; European Renal Best Practice (ERBP) Diabetes Guideline Development Group: Dialysis modality choice in diabetic patients with end-stage kidney disease: A systematic review of the available evidence. Nephrol Dial Transplant 30: 310–320, 2015 PubMed
Li PK, Rosenberg ME: Foreign perspective on achieving a successful peritoneal dialysis-first program. Kidney360 1: 680–684, 2020 PubMed
Li PK, Bavanandan S, Mohamed R, Szeto CC, Wong VW, Chow KM, et al: 2018 kidney disease: Improving global outcomes (KDIGO) hepatitis C in chronic kidney disease guideline implementation: Asia Summit conference report. Kidney Int Rep 5: 1129–1138, 2020 PubMed
Sukul N, Mukhopadhyay P, Schaubel DE, Pearson J, Turenne M, Saran R, et al: Peritoneal dialysis and mortality, kidney transplant, and transition to hemodialysis: Trends from 1996-2015 in the United States. Kidney Med 2: 610–619.e1, 2020 PubMed
Bayani DBS, Almirol BJQ, Uy GDC, Taneo MJS, Danguilan RS, Arakama MI, et al: Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines. Nephrology (Carlton) 26: 170–177, 2021 PubMed
Gupta D, Jyani G, Ramachandran R, Bahuguna P, Ameel M, Dahiya BB, et al: Peritoneal dialysis-first initiative in India: A cost-effectiveness analysis. Clin Kidney J 15: 128–135, 2021 PubMed
Shukri A, Mettang T, Scheckel B, Schellartz I, Simic D, Scholten N, et al: Hemodialysis and peritoneal dialysis in germany from a health economic view: A propensity score matched analysis. Int J Environ Res Public Health 19: 14007, 2022 PubMed
Weinhandl ED, Saffer TL, Aragon M: Hidden costs associated with conversion from peritoneal dialysis to hemodialysis. Kidney360 3: 883–890, 2022 PubMed
Gray NA, Wolley M, Liew A, Nakayama M: Natural disasters and dialysis care in the Asia-Pacific. Nephrology (Carlton) 20: 873–880, 2015 PubMed
Brown EA, Perl J: Increasing peritoneal dialysis use in response to the COVID-19 pandemic: Will it go viral? J Am Soc Nephrol 31: 1928–1930, 2020 PubMed
Okpechi IG, Jha V, Cho Y, Ye F, Ijezie CI, Jindal K, et al: The case for increased peritoneal dialysis utilization in low- and lower-middle-income countries. Nephrology (Carlton) 27: 391–403, 2022 PubMed
Johansen KL, Chertow GM, Gilbertson DT, Ishani A, Ishrani A, Ku E, et al.: US Renal Data System 2022 Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis 2023;81:Sviii-Sxi;S1-S674.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1726 | 1642 | 36 |
Full Text Views | 809 | 659 | 21 |
PDF Downloads | 1015 | 833 | 34 |
© 2020 American Society of Nephrology
Powered by: PubFactory